Alnara Pharmaceuticals Lands $35,000,000 Series B Funding Round

  • Feed Type
  • Date
    1/28/2010
  • Company Name
    Alnara Pharmaceuticals
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139
  • Company Description
    Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases.
  • Website
    http://www.alnara.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $35,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The money will be needed to complete the application and prepare for the potential commercial introduction of liprotamase, which could hit the U.S. market as early as the fourth quarter of this year.
  • M&A Terms
  • Venture Investor
    MPM Capital
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    Third Rock Ventures

By posting a comment, you agree to our terms and conditions.